证券代码：600750 证券简称：江中药业 公告编号： 2025-064 (五)网络投票的系统、起止日期和投票时间。 江中药业股份有限公司 关于召开2025年第二次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、召开会议的基本情况 (一)股东大会类型和届次 2025年第二次临时股东大会 召开的日期时间：2025 年 12 月 29 日 14 点 50 分 召开地点：江西省南昌市新建区招贤 1 路江中药谷会议室 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 12 月 29 日 至2025 年 12 月 29 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段，即 9:15-9:25，9:30-11:30，13:00-15:00；通 过互联网投票平台的投票时间为股东大会召开当日的 9:15-15:00。 (六)融资融券、转融通、约定购回业务账户和沪股通投资者的投票程序 涉及融资融券、转融通业务、约定购回业务 ...

证券代码：600750 证券简称：江中药业 公告编号：2025- 061 为进一步规范公司运作、完善公司治理，根据《公司法》《上市公司章程指 引》等相关法律法规、规范性文件的规定，同意公司不再设置监事会，由董事 会审计委员会行使监事会的职权，公司《监事会议事规则》相应废止，并对 《公司章程》及相关制度同步进行修订。 在公司股东大会审议通过取消监事会事项前，公司第十届监事会仍将严格 按照《公司法》等法律法规和规范性文件的要求，勤勉尽责履行监督职能，继 续对公司经营、公司财务及公司董事、高级管理人员履职的合法合规性进行监 督，维护公司和全体股东的利益。 江中药业股份有限公司 第十届监事会第九次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 江中药业股份有限公司（以下简称"公司"）第十届监事会第九次会议于 2025 年 12 月 12 日在公司会议室以现场结合视频方式召开，会议通知于 2025 年 12 月 7 日以书面形式发出，应参会监事 3 人，实到 3 人。会议召集召开符合 《公司法》和《公司章程》的有关规 ...

证券代码：600750 证券简称：江中药业 公告编号：2025- 060 江中药业股份有限公司 第十届董事会第十次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 江中药业股份有限公司（以下简称"公司"或"江中药业"）第十届董事会 第十次会议于 2025 年 12 月 12 日在公司会议室以现场结合视频方式召开，会议 通知于 2025 年 12 月 7 日以书面形式发出，会议应到董事 9 人，实到董事 9 人。 公司监事和高级管理人员列席。本次会议召集召开符合《公司法》和《公司章 程》的有关规定。 会议由公司董事长刘为权先生主持，经与会董事充分研究和讨论，审议通 过以下议案： 一、关于变更公司名称及证券简称、变更注册资本、取消监事会并修订 《公司章程》的议案 表决情况：8 票同意，0 票反对，0 票弃权，通过本议案。 为强化与华润的品牌协同认知，进一步提升公司品牌辨识度和市场影响力， 公司拟将中文名称变更为"华润江中药业股份有限公司"，英文名称变更为 "China Resources Jiangzhong P ...

截至发稿，江中药业市值为155亿元。 每经头条（nbdtoutiao）——实施城乡居民增收计划、降准降息等工具灵活高效运用、增加普通高中学 位……深度解读中央经济工作会议 （记者 贾运可） 每经AI快讯，江中药业（SH 600750，收盘价：24.38元）12月12日晚间发布公告称，公司第十届第十次 董事会会议于2025年12月12日在公司会议室以现场结合视频方式召开。会议审议了《关于制定、修订公 司治理制度的议案》等文件。 2025年1至6月份，江中药业的营业收入构成为：医药工业占比99.64%，酒业占比0.25%，其他业务占比 0.11%。 ...

每经AI快讯，12月12日，江中药业（600750）(600750.SH)公告称，公司拟将中文名称变更为"华润江中 药业股份有限公司"，英文名称变更为"China Resources Jiangzhong Pharmaceutical Co.,Ltd"，证券简称变 更为"华润江中"，证券代码保持不变。 ...

Group 1 - The company has adopted a bill pool model for issuing bank acceptance bills to optimize fund management efficiency [2]

Core Insights - The article highlights the top-performing stocks in the S&P China A-Share Dividend Opportunity Index (CSPSADRP) as of December 12, 2025, showcasing significant daily and year-to-date gains along with dividend yields [1][4]. Group 1: Top Performers - The top stock, Jiufeng Energy (605090.SH), recorded a daily increase of 3.12% and a year-to-date increase of 25.95%, with a dividend yield of 3.43% [1][4]. - Furi Shares (002083.SZ) achieved a daily rise of 3.00% and an impressive year-to-date increase of 131.27%, with a dividend yield of 1.35% [1][4]. - Aotewei (688516.SH) saw a daily gain of 2.67% and a year-to-date increase of 3.38%, with a dividend yield of 5.11% [1][4]. Group 2: Notable Trends - The data indicates that several stocks, such as Yuyuan Group (601686.SH) and Agricultural Bank of China (601288.SH), have shown consistent performance with year-to-date increases of 26.26% and 55.18%, respectively [1][4]. - Stocks like Gree Electric (000651.SZ) and China Petroleum (601857.SH) have experienced fluctuations, with year-to-date changes of -4.59% and 14.06%, respectively, indicating varying market conditions [1][4]. - The overall performance of the index reflects a mix of high-growth stocks and those facing challenges, suggesting a diverse investment landscape within the Chinese A-share market [1][4].

Market Overview - The global probiotic market reached a size of $60.23 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 8.7%, potentially reaching $93.49 billion by 2028 [3] - The Chinese probiotic market surpassed 100 billion yuan in 2022, reaching 106.5 billion yuan, with expectations to grow to 137.7 billion yuan by 2026 [3] Company Insights - Jiangzhong has been recognized as the "No. 1 in China for probiotic freeze-dried powder sales" in 2024, indicating strong market performance [6] - The company focuses on gut health with its P9 probiotic freeze-dried powder, which includes 19 strains of probiotics, enhancing gut flora and promoting the proliferation of beneficial bacteria [7] Product Development - The core strain, Lactobacillus plantarum P9, has undergone eight years of research and has been clinically validated for its effectiveness in regulating gut microbiota and improving conditions like constipation and chronic diarrhea [7][9] - Jiangzhong employs advanced encapsulation technology and liquid nitrogen freezing to enhance the survival rate of probiotics during transport and digestion, ensuring their effectiveness upon reaching the gut [9]

Core Insights - The article highlights the top-performing stocks in the S&P China A-Share Dividend Opportunity Index (CSPSADRP) as of December 2, 2025, showcasing significant daily and year-to-date gains along with dividend yields [1][4]. Summary by Category Stock Performance - The top stock, 思维列控 (Code: 603508.SH), recorded a daily increase of 6.38% and a year-to-date increase of 38.28%, with a dividend yield of 12.69% [1][4]. - 建霖家居 (Code: 603408.SH) and 欧普照明 (Code: 603515.SH) also showed strong performance, with daily increases of 3.25% and 2.61%, and year-to-date increases of 11.24% and 15.74%, respectively [1][4]. - 录日股份 (Code: 002083.SZ) stands out with an impressive year-to-date increase of 118.84%, despite a lower daily increase of 1.96% [1][4]. Dividend Yields - The highest dividend yield among the top performers is from 永新股份 (Code: 002014.SZ) at 7.98%, with a year-to-date increase of 12.58% [1][4]. - Other notable dividend yields include 志邦家居 (Code: 603801.SH) at 6.47% and 思维列控 (Code: 603508.SH) at 12.69% [1][4]. Market Trends - The article indicates a positive market trend with the formation of MACD golden cross signals, suggesting potential upward momentum for the highlighted stocks [3][6].

Group 1 - The core viewpoint of the article highlights the significant growth of index investment, with the scale of stock ETFs reaching 4.11 trillion yuan by Q3 2025, while the total scale of passive index funds (including ETFs) reached 4.44 trillion yuan [2][6] - The number of passive index funds tracking A-share stock indices has increased to 1,521, with 56 indices having a tracking scale exceeding 10 billion yuan as of November 28, 2025 [5][6] - Major indices with the largest tracking scales include the CSI 300 at 1,181.33 billion yuan, the CSI A500 at 195.35 billion yuan, and the SSE 50 at 188.34 billion yuan [7] Group 2 - The article discusses the impact of index component stock adjustments, which are conducted biannually by index companies, potentially creating trading opportunities due to significant changes in component stocks [6][8] - The methodology for measuring the impact of these adjustments includes calculating the net adjustment scale for individual stocks based on their buy and sell volumes across different indices [9][10] - Stocks expected to see significant net buying include Shenghong Technology, Dongshan Precision, and Guangqi Technology, with projected net buying scales of 4.865 billion yuan, 4.791 billion yuan, and 3.487 billion yuan respectively [10][11] Group 3 - The article identifies stocks with a projected net selling scale exceeding 5 billion yuan, including Yangguang Electric Power, Zhongji Xuchuang, and Hanwha Technology, with expected net selling scales of 5.679 billion yuan, 3.898 billion yuan, and 3.125 billion yuan respectively [12][13] - Stocks with high impact coefficients, indicating significant potential market impact due to adjustments, include Taipai Group, Jiangzhong Pharmaceutical, and Shandong Power, with coefficients of 8.69, 8.44, and 6.99 respectively [11][12]